182 related articles for article (PubMed ID: 15498032)
1. Chemical induction of HO-1 suppresses lupus nephritis by reducing local iNOS expression and synthesis of anti-dsDNA antibody.
Takeda Y; Takeno M; Iwasaki M; Kobayashi H; Kirino Y; Ueda A; Nagahama K; Aoki I; Ishigatsubo Y
Clin Exp Immunol; 2004 Nov; 138(2):237-44. PubMed ID: 15498032
[TBL] [Abstract][Full Text] [Related]
2. Heme oxygenase-1 induction attenuates inducible nitric oxide synthase expression and proteinuria in glomerulonephritis.
Datta PK; Koukouritaki SB; Hopp KA; Lianos EA
J Am Soc Nephrol; 1999 Dec; 10(12):2540-50. PubMed ID: 10589693
[TBL] [Abstract][Full Text] [Related]
3. Interactions between inducible nitric oxide synthase and heme oxygenase-1 in glomerulonephritis.
Datta PK; Gross EJ; Lianos EA
Kidney Int; 2002 Mar; 61(3):847-50. PubMed ID: 11849436
[TBL] [Abstract][Full Text] [Related]
4. Activation of toll-like receptor-9 induces progression of renal disease in MRL-Fas(lpr) mice.
Anders HJ; Vielhauer V; Eis V; Linde Y; Kretzler M; Perez de Lema G; Strutz F; Bauer S; Rutz M; Wagner H; Gröne HJ; Schlöndorff D
FASEB J; 2004 Mar; 18(3):534-6. PubMed ID: 14734643
[TBL] [Abstract][Full Text] [Related]
5. Clear suppression of Th1 responses but marginal amelioration of autoimmune manifestations by IL-12p40 transgene in MRL-FAS(lprcg)/FAS(lprcg) mice.
Yasuda T; Yoshimoto T; Tsubura A; Matsuzawa A
Cell Immunol; 2001 Jun; 210(2):77-86. PubMed ID: 11520074
[TBL] [Abstract][Full Text] [Related]
6. Effect of mycophenolate mofetil on severity of nephritis and nitric oxide production in lupus-prone MRL/lpr mice.
Lui SL; Tsang R; Wong D; Chan KW; Chan TM; Fung PC; Lai KN
Lupus; 2002; 11(7):411-8. PubMed ID: 12195781
[TBL] [Abstract][Full Text] [Related]
7. CD47 deficiency ameliorates autoimmune nephritis in Fas(lpr) mice by suppressing IgG autoantibody production.
Shi L; Bian Z; Chen CX; Guo YN; Lv Z; Zeng C; Liu Z; Zen K; Liu Y
J Pathol; 2015 Nov; 237(3):285-95. PubMed ID: 26095930
[TBL] [Abstract][Full Text] [Related]
8. Anti-T cell receptor antibody treatment of mice with lupus-like graft versus host disease: suppression of glomerulonephritis without reduction in anti-DNA antibody levels.
Maeda T; Nomoto K
J Rheumatol; 1995 Dec; 22(12):2259-65. PubMed ID: 8835559
[TBL] [Abstract][Full Text] [Related]
9. The beneficial effects of treatment with all-trans-retinoic acid plus corticosteroid on autoimmune nephritis in NZB/WF mice.
Nozaki Y; Yamagata T; Yoo BS; Sugiyama M; Ikoma S; Kinoshita K; Funauchi M; Kanamaru A
Clin Exp Immunol; 2005 Jan; 139(1):74-83. PubMed ID: 15606616
[TBL] [Abstract][Full Text] [Related]
10. Amelioration of autoimmune nephritis by imatinib in MRL/lpr mice.
Sadanaga A; Nakashima H; Masutani K; Miyake K; Shimizu S; Igawa T; Sugiyama N; Niiro H; Hirakata H; Harada M
Arthritis Rheum; 2005 Dec; 52(12):3987-96. PubMed ID: 16320345
[TBL] [Abstract][Full Text] [Related]
11. Piperlongumine alleviates lupus nephritis in MRL-Fas(lpr) mice by regulating the frequency of Th17 and regulatory T cells.
Yao L; Chen HP; Ma Q
Immunol Lett; 2014 Sep; 161(1):76-80. PubMed ID: 24837470
[TBL] [Abstract][Full Text] [Related]
12. Dual immuno-renal targeting of 7-benzylidenenaltrexone alleviates lupus nephritis via FcγRIIB and HO-1.
Tseng TC; Huang DY; Lai LC; Hwai H; Hsiao YW; Jhou JP; Chuang EY; Tzeng SJ
J Mol Med (Berl); 2018 May; 96(5):413-425. PubMed ID: 29508016
[TBL] [Abstract][Full Text] [Related]
13. Effect of neutralizing antibodies to IL-10 and C5 on the renal damage caused by a pathogenic human anti-dsDNA antibody.
Ravirajan CT; Wang Y; Matis LA; Papadaki L; Griffiths MH; Latchman DS; Isenberg DA
Rheumatology (Oxford); 2004 Apr; 43(4):442-7. PubMed ID: 15024133
[TBL] [Abstract][Full Text] [Related]
14. Cross-reactivity of human lupus anti-DNA antibodies with alpha-actinin and nephritogenic potential.
Zhao Z; Weinstein E; Tuzova M; Davidson A; Mundel P; Marambio P; Putterman C
Arthritis Rheum; 2005 Feb; 52(2):522-30. PubMed ID: 15693007
[TBL] [Abstract][Full Text] [Related]
15. Heme oxygenase is induced in nephrotoxic nephritis and hemin, a stimulator of heme oxygenase synthesis, ameliorates disease.
Mosley K; Wembridge DE; Cattell V; Cook HT
Kidney Int; 1998 Mar; 53(3):672-8. PubMed ID: 9507213
[TBL] [Abstract][Full Text] [Related]
16. Mycophenolate mofetil reduces renal cortical inducible nitric oxide synthase mRNA expression and diminishes glomerulosclerosis in MRL/lpr mice.
Yu CC; Yang CW; Wu MS; Ko YC; Huang CT; Hong JJ; Huang CC
J Lab Clin Med; 2001 Jul; 138(1):69-77. PubMed ID: 11433230
[TBL] [Abstract][Full Text] [Related]
17. Nephritogenic anti-DNA antibodies regulate gene expression in MRL/lpr mouse glomerular mesangial cells.
Qing X; Zavadil J; Crosby MB; Hogarth MP; Hahn BH; Mohan C; Gilkeson GS; Bottinger EP; Putterman C
Arthritis Rheum; 2006 Jul; 54(7):2198-210. PubMed ID: 16804897
[TBL] [Abstract][Full Text] [Related]
18. Dysregulated heme oxygenase-1
Kishimoto D; Kirino Y; Tamura M; Takeno M; Kunishita Y; Takase-Minegishi K; Nakano H; Kato I; Nagahama K; Yoshimi R; Igarashi K; Aoki I; Nakajima H
Arthritis Res Ther; 2018 Apr; 20(1):64. PubMed ID: 29636091
[TBL] [Abstract][Full Text] [Related]
19. L-arginine supplementation accelerates renal fibrosis and shortens life span in experimental lupus nephritis.
Peters H; Border WA; Rückert M; Krämer S; Neumayer HH; Noble NA
Kidney Int; 2003 Apr; 63(4):1382-92. PubMed ID: 12631354
[TBL] [Abstract][Full Text] [Related]
20. A monoclonal DNA-binding autoantibody causes a deterioration in renal function in MRL mice with lupus disease.
Lake RA; Staines NA
Clin Exp Immunol; 1988 Jul; 73(1):103-10. PubMed ID: 3048810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
